Imiquimod Raw Material (CAS 99011-02-6) | Genital warts drug

» farmacêutico » outras APIs » Imiquimod Raw Material (CAS 99011-02-6) | Genital warts drug

Imiquimod Raw Material (CAS 99011-02-6) | Genital warts drug

CATEGORIA E TAGS:
outras APIs , , , , , , ,

Fórmula molecular:C14H16N4
Formula Weight: 240.3
CAS No.:99011-02-6
Aparência:white powder
Pureza:99.89%

inquérito
  • Especificações

Buy Genital warts drug Imiquimod Raw Material (CAS 99011-02-6)

 

Imiquimod Description

Imiquimod is belonging to the drug for the treatment of genital warts. Clinically it can be used as the immunomodulators in the treatment of adult genital and perianal warts with convenient application, well tolerance and unique mechanism of action which makes it be the first-choice drug for treatment of genital warts.

 

Imiquimod Certificate of Analysis

Itens de análise Especificação Resultados
Aparência Off-white powder,dissolve in hydrochloric conform
Ponto de fusão

 

297-299℃ 298.2-298.7℃
Identificação IR UV/HPLC conform
Ensaio 98-101% 99.89%
Pureza ≥99% 99.87%
Related substance ≤0.1% 0.13%
Metais pesados ≤10ppm conform
Perda ao secar ≤0.5% ≤0.5%
Resíduo de ignição ≤0.2% 0.02%
Conclusão Qualificado

 

Imiquimod Usage

Imiquimod can be used for the treatment of adult external genital and perianal genital warts at 3 times per week. Just before sleep, first apply the product evenly in a thin layer on the surface of the wart and gently massage until the product is completely absorbed.

The position of the medication should not be packeted and should be maintained for 6 para 10 hours, and then wash with a neutral soap and clean water for clearing the drugs in the administration site. Wash your hands before and after treatment.

250 mg of cream can be applied to 20cm2 of wart. Avoid excessive application of the drug. Patients should continue the treatment until the wart is completely cleared. Wart can be cleared within 2-4 week at the fastest speed and can be generally cleared within 8 para 12 semanas. The medication should be not more than 16 semanas.

After the treatment, patients with mild erythema locally who does not have to be discontinued for drug; if the patients feel general malaise or get local skin reactions (edema, erosion, pain, etc.), the drug should be discontinued. Only when the reaction is alleviated can they continue the medication.

Formulário de inquérito ( nós entraremos em contato o mais breve possível )

Nome:
*
O email:
*
mensagem:

Verificação:
5 + 8 = ?

Talvez você gosta também

  • Categorias de Produtos

  • Postagens recentes

  • Compartilhar

  • Contate-Nos

    E-mail: ying@wumeitech.com
    Tel: 86-0756-8811069
    Fax: 86-0756-8811095
    Tel / whatsapp: +86 17707567122
    Wicker ID: molly160529
    Telegrama: +86 17707567122